Cheil Bio Co

Cheil Bio Co Forward P/E

Delisted·Feb 25, 2026

The Forward P/E Ratio of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -14.92. In the previous year, Forward P/E Ratio was -4.30 — a change of 247.06% (lower).

Forward P/E

-14.92

YoY

247.06%

Last updated:

Forward P/E Ratio of Cheil Bio Co is 2024 -14.92 . Forward P/E Ratio of Cheil Bio Co was 2023 -4.30 . It decreases by 247.06% lower compared to the previous year.

The Cheil Bio Co Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2017
7.87 KRW
Jan 1, 2018
5.97 KRW
Jan 1, 2019
3.04 KRW
Jan 1, 2020
6.25 KRW
Jan 1, 2021
-8.72 KRW
Jan 1, 2022
-3.64 KRW
Jan 1, 2023
-4.30 KRW
Jan 1, 2024
-14.92 KRW
The Cheil Bio Co Forward P/E history
YEARForward P/EYoY
-14.92+247.06%
-4.30+18.13%
-3.64-58.29%
-8.72-239.51%
6.25+105.56%
3.04-49.08%
5.97-24.13%
7.87+28.48%
6.13-16.00%
7.30+12.22%
6.50—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Forward P/E Ratio of Cheil Bio Co is -14.92 in 2024.

Forward P/E Ratio of Cheil Bio Co changed from -4.30 to -14.92, representing a 247.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cheil Bio Co

All Key Metrics — Cheil Bio Co